Trial Profile
A randomized, double-blind crossover study to investigate the potential glucose-lowering interaction between ethanol and GK Activator (2) [RO 4389620] in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Piragliatin (Primary) ; Alcohol
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Roche
- 08 Jan 2008 New trial record.